Mayur Ian Somaiya, Chief Financial Officer of NewAmsterdam Pharma Co N.V. (NASDAQ:NAMS), a $2.24 billion market cap pharmaceutical company, recently executed several transactions involving the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback